# FIH Lead-in Study of YASO GEL Followed by a Phase 1 Randomized, Double-blind Study to Assess Safety and Pharmacokinetics of YASO GEL

> **NCT07281404** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Yaso Therapeutics Corporation** · enrollment: 72 (estimated)

## Conditions studied

- Early-phase Safety and PK Study of a Vaginal Gel

## Interventions

- **DRUG:** YASO GEL
- **DRUG:** Placebo gel

## Key facts

- **NCT ID:** NCT07281404
- **Lead sponsor:** Yaso Therapeutics Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2028-02
- **Final completion:** 2028-02
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2025-12-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07281404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07281404, "FIH Lead-in Study of YASO GEL Followed by a Phase 1 Randomized, Double-blind Study to Assess Safety and Pharmacokinetics of YASO GEL". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT07281404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*